EnGene Holdings Ownership

ENGN Etf  USD 7.61  0.60  8.56%   
EnGene Holdings holds a total of 50.98 Million outstanding shares. The majority of enGene Holdings Common outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in enGene Holdings Common to benefit from reduced commissions. Accordingly, institutional investors are subject to a different set of regulations than regular investors in EnGene Holdings. Please pay attention to any change in the institutional holdings of enGene Holdings Common as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in etfs such as EnGene Holdings in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of EnGene Holdings, and when they decide to sell, the etf will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in enGene Holdings Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in price.

EnGene Etf Ownership Analysis

The fund retains about 97.03% of assets under management (AUM) in fixed income securities. To learn more about enGene Holdings Common call JD Esq at 514 332 4888 or check out https://www.engene.com.

enGene Holdings Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnGene Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnGene Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnGene Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over three weeks ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5997 shares of EnGene Holdings at 6.5436 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over a month ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 561797 shares of EnGene Holdings at 8.9 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 800 shares of EnGene Holdings at 6.5981 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 11844 shares of EnGene Holdings at 6.546 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5997 shares of EnGene Holdings at 6.5436 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 10153 shares of EnGene Holdings at 6.3722 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 341332 shares of EnGene Holdings at 6.338 subject to Rule 16b-3
 
Ronald Cooper over two months ago
Acquisition by Ronald Cooper of 10000 shares of EnGene Holdings at 5.7 subject to Rule 16b-3
 
Glickman Richard M over three months ago
Acquisition by Glickman Richard M of 4123 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Glickman Richard M over six months ago
Acquisition by Glickman Richard M of 120 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Glickman Richard M over six months ago
Acquisition by Glickman Richard M of 11189 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Forbion Capital Fund Iii Cooperatief U.a. over six months ago
Disposition of tradable shares by Forbion Capital Fund Iii Cooperatief U.a. of EnGene Holdings subject to Rule 16b-3

Pair Trading with EnGene Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnGene Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against EnGene Etf

  0.64ME 23Andme HoldingPairCorr
  0.47DOMH Dominari HoldingsPairCorr
  0.46DTIL Precision BioSciencesPairCorr
  0.42DNLI Denali TherapeuticsPairCorr
  0.4A Agilent TechnologiesPairCorr
The ability to find closely correlated positions to EnGene Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnGene Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnGene Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enGene Holdings Common to buy it.
The correlation of EnGene Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnGene Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enGene Holdings Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnGene Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in EnGene Etf

EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.